The government is reviewing the Supreme Court’s Sterling Biotech judgment, which dropped criminal charges against promoters in exchange for a ₹5,100 crore payment. While not a precedent, the ruling raises concerns for lenders and could impact similar fraud cases, potentially encouraging other offenders to seek settlements.
